Document is current
Any future updates will be listed below
-
Authors
Legros, Laurence https://orcid.org/0000-0002-9567-7879
Pascale, Alina https://orcid.org/0000-0001-9511-3726
Guettier, Catherine https://orcid.org/0000-0003-0791-5505
Eftekhari, Pirayeh
Merabet, Yasmina Ben
Stang, Maryse
Bossevot, Rachel https://orcid.org/0000-0002-6646-2481
Goldschmidt, Emma https://orcid.org/0000-0002-2153-5384
Ulusakarya, Ayhan https://orcid.org/0000-0001-8683-6818
Morisset, Stephane https://orcid.org/0000-0002-7747-113X
Lewin, Maïté https://orcid.org/0000-0002-9450-8096
Samuel, Didier https://orcid.org/0000-0001-9481-3616
Rosmorduc, Olivier https://orcid.org/0000-0002-6695-3088
- License Information
-
More Information
Article History
Received: 2 December 2022
Accepted: 3 March 2023
First Online: 24 March 2023
Declarations
:
: LL reports personal fees from Bristol Myers-Squibb (BMS), Incyte, Novartis, and Pfizer and research support from Incyte outside of the submitted work. OR reports participation on data safety monitoring boards or advisory boards for Bayer, Eisai, and Sitrex.
